The Korea Times close
National
  • Politics
  • Diplomacy
  • Defense
  • Labor & Environment
  • Law & Crime
  • Health & Welfare
  • Embassy
  • Seoul & Provinces
  • Education
  • Foreign Communities
  • Obituaries
Biz & Tech
  • Auto
  • IT
  • Game
  • Manufacturing
  • Retail & Food
  • Energy
  • Construction
  • Airlines
Finance
  • Policies
  • Economy
  • Markets
  • Banks
  • Non-banks
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
Lifestyle
  • Arts
  • Books
  • Travel & Cuisine
  • Trend
  • Fashion
  • Around Town
  • Fortune Telling
Entertainment
  • K-pop
  • K-dramas & Shows
  • Movies
  • Music
  • Performances
  • Asia Model Festival
Sports
  • Football
  • Golf
  • Baseball
  • Other Sports
World
  • Asia Pacific
  • Americas
  • Europe & Africa
  • SCMP
Video
  • On the Spot
  • Feature
  • News
Photos
  • Photo News
  • Darkroom
Community
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Diplomacy
  • Defense
  • Labor & Environment
  • Law & Crime
  • Health & Welfare
  • Embassy
  • Seoul & Provinces
  • Education
  • Foreign Communities
  • Obituaries
Fri, April 16, 2021 | 02:11
Health & Welfare
Homegrown coronavirus treatment expected to be used from next month: PM
Posted : 2021-01-18 10:45
Updated : 2021-01-18 10:45
Mail
Print Preview
Font Size Up
Font Size Down
Gettyimagesbank
Gettyimagesbank

South Korea's first homegrown coronavirus treatment candidate from Celltrion Inc. is expected to be used to treat patients starting early February, Prime Minister Chung Sye-kyun said Monday.

"We expect the drug to be used from early next month in antivirus activities in the field if the review process goes smoothly," Chung said during an interagency meeting on the COVID-19 response held at the government complex in Seoul.

The prime minister said health authorities convened a panel of experts to review the safety and efficacy of the drug. According to Chung, the government is scheduled to announce the results of the meeting later in the day.

Celltrion announced last week that it has conducted the trial on 327 patients of the novel coronavirus to evaluate the efficacy and safety of CT-P59, also known as Regdanvimab. It said that CT-P59 decreased the rate of COVID-19 patients developing severe cases, which require hospital care, by 54 percent.

The firm earlier submitted an application for conditional marketing authorization of the product to the Korean Ministry of Food and Drug Safety.

Also during the government meeting, Chung noted that the nation's new coronavirus cases dropped to the 300 range for the first time since November, highlighting the significant decline in cases from late last year.

"The number of new cases fell to the 300 range for the first time since late November. We begin this week with a pledge to achieve a clear trend of stability (in the virus situation)," Chung said.

The country added 389 more COVID-19 cases, including 366 local infections, raising the total caseload to 72,729, according to the Korea Disease Control and Prevention Agency.

Monday's daily figure marked a sharp fall from 520 posted a day earlier and is the smallest daily caseload since Nov. 25.

The third wave of COVID-19 here reached its peak on Dec. 25, with the daily tally reaching 1,240, but has been showing signs of a slowdown since. The daily figure has been staying in the 500s for the past six days. (Yonhap)


President Moon assures citizens of COVID-19 vaccination safety
President Moon Jae-in said Monday that the country's drug safety ministry will thoroughly verify the safety of COVID-19 vaccines before the beginning of inoculations next month, in...
Korea reports 1st COVID-19 variant case from Brazil
South Korea's health authorities on Monday confirmed the country's first case of the new coronavirus variant that was first identified in Brazil. The latest discovery brings the to...
New virus cases at almost 2-month low on fewer tests, infections slowdown
South Korea's daily new coronavirus cases rose by the smallest number in nearly two months Monday, apparently on the back of tightened social distancing measures and fewer tests ov...









 
LG
 
  • Wife of Belgium ambassador accused of assaulting clothing shop worker
  • Drunk driver sentenced to 8 years in prison for hitting and killing Taiwanese student
  • COVID-19 infections likely to spike further; gov't set to raise social distancing level
  • NFTs: Future of fine arts market?
  • SsangYong Motor again under court receivership
  • Korea urged to work with China, Russia to counter Fukushima water disposal
  • Korean battery makers scrambling to increase production in US
  • New virus cases around 700 for 2nd day
  • Police tighten security measures in Muslim communities for safety during Ramadan
  • Rwanda commemorates 27th anniversary of 1994 Genocide against Tutsi
  • Seo Yea-ji's career goes into tailspin amid multiple allegations of misconduct Seo Yea-ji's career goes into tailspin amid multiple allegations of misconduct
  • MAMAMOO's Wheein takes music charts by storm with 'Water Color' MAMAMOO's Wheein takes music charts by storm with 'Water Color'
  • [INTERVIEW] Yeo Jin-goo on how 'Beyond Evil' gave him confidence as actor [INTERVIEW] Yeo Jin-goo on how 'Beyond Evil' gave him confidence as actor
  • BTS member Jimin's 'hanbok' suit up for auction BTS member Jimin's 'hanbok' suit up for auction
  • Ji Chang-wook to take lead role in new Netflix series 'The Sound of Magic' Ji Chang-wook to take lead role in new Netflix series 'The Sound of Magic'
DARKROOM
  • Locust outbreak

    Locust outbreak

  • Death toll rises as protests continue in Myanmar

    Death toll rises as protests continue in Myanmar

  • Say 'NO' to racism (Part 2)

    Say 'NO' to racism (Part 2)

  • Say 'NO' to racism (Part 1)

    Say 'NO' to racism (Part 1)

  • Worst dust storm chokes Beijing

    Worst dust storm chokes Beijing

The Korea Times
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Location
  • Media Kit
  • Contact Us
  • Products & Service
  • Subscribe
  • E-paper
  • Mobile Service
  • RSS Service
  • Content Sales
  • Policy
  • Privacy Statement
  • Terms of Service
  • 고충처리인
  • Youth Protection Policy
  • Code of Ethics
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group